Abstract
Chemo-inducible cancer gene therapy is a potential new treatment for solid tumors that may in part enhance the anti-tumor effects of chemotherapy while minimizing toxicity. This approach combines viral vectors expressing cytotoxic transgenes that can be transcriptionally activated by DNA-damaging agents. The development of chemo-inducible gene therapy has numerous implications for the treatment of both localized and metastatic disease in patients with solid tumors.
MeSH terms
-
Antineoplastic Agents / pharmacology
-
Antineoplastic Agents / therapeutic use*
-
Combined Modality Therapy
-
DNA / drug effects
-
DNA Damage
-
Early Growth Response Protein 1 / genetics
-
Genes, MDR / genetics
-
Genetic Therapy / methods*
-
Humans
-
Neoplasms / drug therapy
-
Neoplasms / genetics
-
Neoplasms / therapy*
-
Promoter Regions, Genetic / genetics
-
Transcription, Genetic / drug effects*
-
Transcription, Genetic / radiation effects
-
Tumor Necrosis Factors / genetics
Substances
-
Antineoplastic Agents
-
EGR1 protein, human
-
Early Growth Response Protein 1
-
Tumor Necrosis Factors
-
DNA